Cargando…

PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA

Detalles Bibliográficos
Autores principales: Kahl, B., Cohen, J., Pillai, R., Jayaprakash, V., Wang, C., Hahka-Kemppinen, M., Kania, M., Zinzani, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431547/
http://dx.doi.org/10.1097/01.HS9.0000850372.60201.c7
_version_ 1784780084633141248
author Kahl, B.
Cohen, J.
Pillai, R.
Jayaprakash, V.
Wang, C.
Hahka-Kemppinen, M.
Kania, M.
Zinzani, P.
author_facet Kahl, B.
Cohen, J.
Pillai, R.
Jayaprakash, V.
Wang, C.
Hahka-Kemppinen, M.
Kania, M.
Zinzani, P.
author_sort Kahl, B.
collection PubMed
description
format Online
Article
Text
id pubmed-9431547
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94315472022-08-31 PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA Kahl, B. Cohen, J. Pillai, R. Jayaprakash, V. Wang, C. Hahka-Kemppinen, M. Kania, M. Zinzani, P. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431547/ http://dx.doi.org/10.1097/01.HS9.0000850372.60201.c7 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Kahl, B.
Cohen, J.
Pillai, R.
Jayaprakash, V.
Wang, C.
Hahka-Kemppinen, M.
Kania, M.
Zinzani, P.
PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_full PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_fullStr PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_full_unstemmed PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_short PB1880: A MULTICENTER PHASE 1 STUDY EVALUATING THE SAFETY AND TOLERABILITY OF HMPL-760 IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA OR OTHER NON-HODGKIN LYMPHOMA
title_sort pb1880: a multicenter phase 1 study evaluating the safety and tolerability of hmpl-760 in patients with previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma or other non-hodgkin lymphoma
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431547/
http://dx.doi.org/10.1097/01.HS9.0000850372.60201.c7
work_keys_str_mv AT kahlb pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT cohenj pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT pillair pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT jayaprakashv pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT wangc pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT hahkakemppinenm pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT kaniam pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma
AT zinzanip pb1880amulticenterphase1studyevaluatingthesafetyandtolerabilityofhmpl760inpatientswithpreviouslytreatedchroniclymphocyticleukemiasmalllymphocyticlymphomaorothernonhodgkinlymphoma